Behaviour change interventions
Key Correspondents | 8 hours ago
Controversy over an advert on condom use to prevent HIV among married couples led by a cross section of Kenyan religious leaders has left many HIV activists astonished at the ‘denial of reality’.
HIV and criminal law
Positive Lite | 9 hours ago
An extraordinary example of HIV criminalization gone awry in the States. Bob Leahy talks to Lt. Colonel Ken Pinkela, court martialed and sentenced to a jail term for allegedly exposing another officer to HIV, when no sexual contact occurred, says Pinkela.
Relationships and feelings
HIV Plus | 9 hours ago
Talking about PrEP with your partner can open up a can of worms. Here's how to make the conversation as smooth as possible.
Access to medicines and treatment
Médecins Sans Frontières press release | 9 hours ago
GS-5816 is an important anti-hepatitis C compound that, in combination with sofosbuvir, will greatly simplify treatment for developing countries. However, it appears that none of the terms and conditions of the original licence agreement has been changed, meaning that the concerns that MSF has with the licence agreement remain, including the limited geographic scope of the agreement, restrictions on the production and export of active pharmaceutical ingredient, and the inclusion of an ethically and medically controversial and problematic anti-diversion clause.
New and experimental hepatitis C treatment
Gilead press release | 9 hours ago
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has expanded its hepatitis C generic licensing agreements to include the investigational NS5A inhibitor GS-5816, which is being evaluated in Phase 3 clinical studies as part of a single tablet regimen that combines the compound and sofosbuvir for the treatment of all six genotypes of hepatitis C. The expanded agreements will allow Gilead’s India-based partners to manufacture GS-5816 and the single tablet regimen of sofosbuvir/GS-5816, once approved, for distribution in 91 developing countries, which together account for 54 percent of the total worldwide population of individuals infected with the hepatitis C virus (HCV).
Recreational drug use
Archer | 26 January 2015
“I’m being destructive, and I know it.” This statement comes from community consultation I did recently with HIV-positive gay men on how they feel they’re being affected by using crystal meth, otherwise known as ice, or tina in the queer community.
Injecting drug use
Talking Drugs | 26 January 2015
Greece's left-wing Syriza party looks set to win the country's upcoming election on the platform of alleviating the economic crisis that has brought Greece to its knees and stoked an HIV epidemic among drug users. Could this mark a turning point for harm reduction services and marginalized groups?
Packaging World | 26 January 2015
Designed to help prevent the spread of HIV/AIDS in sub-Saharan Africa and India, MEMSCap smart electronic medication packaging system tracks each time the medication bottle is opened.
Bad science and bogus treatments
Africa Check | 26 January 2015
HIV/AIDS educators often seem to enjoy raising an eyebrow at outlandish beliefs over the disease. But in doing so they fail to realise that the joke is on them – these ideas continue to hold sway despite their best efforts.
Experiences of stigma
JZ (blog) | 26 January 2015
After decades of education and advocacy, it would be reasonable to assume, that the notion of dirtiness in relation to HIV has diminished from our society. However, I would argue that this is not the case, especially if we look into dating apps / websites and the deployment of PrEP.